Trial intelligence / Profile preview

Zinc Oxide vs MEBO for Stage 2 Pressure Ulcer

NCT07193849Phase 4Recruiting

Sponsor
King Abdullah Medical City
Start
Dec 2023
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of zinc oxide, MEBO Moist Burn Ointment in pressure ulcer, sponsored by King Abdullah Medical City. Started Dec 2023; status: recruiting.

02

Drugs

zinc oxideMEBO Moist Burn Ointment
03

Conditions

pressure ulcer

Beyond the preview

Go deeper on NCT07193849.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07193849.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call